First-line Sintilimab Plus Platinum-Based Chemotherapy Prolongs PFS in Advanced Nonsquamous NSCLC

The Chen-Huang Center for EGFR-Mutant Lung Cancers Represents a ‘Concentrated and Focused Effort’ in Studying Th is Disease Subset

Anne-Marie Baird, BSc, PhD

Managing lung cancer in the time of COVID-19

Leora Horn, MD - IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD - IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib

Paul G. Kluetz, MD

PASSION Results Support Further Study of Camrelizumab Plus Apatinib in SCLC

Shirish Gadgeel, MD

Prior Pneumonitis as a Risk Factor for Treatment-Associated Pneumonitis With Immune Checkpoint Inhibitor Therapy